No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis

Published:2023-02 Issue:2 Volume:86 Page:154-225
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Cheema Huzaifa Ahmad^ORCID,Shafiee Arman,Athar Mohammad Mobin Teymouri,Shahid Abia,Awan Rehmat Ullah^ORCID,Afifi Ahmed M,Shah Jaffer^ORCID,Jalal Prasun K^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference20 articles.

1. Efficacy and safety of Paxlovid for COVID-19:a meta-analysis;Qian;J Infect,2022

2. Minimum manufacturing costs, national prices, and estimated global availability of new repurposed therapies for Coronavirus Disease 2019;Junzheng;Open Forum Infect Dis,2022

3. Efficacy and safety of molnupiravir for COVID-19 patients;Maurish;Eur J Intern Med,2022

4. Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial;Brennan Christina;Gut,2022

5. Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study;Jiandong;Gut,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis;Journal of Microbiology, Immunology and Infection;2024-06

2. Proton pump inhibitors and risk of severe COVID-19 in older people;Age and Ageing;2024-04-01

3. Postacute Sequelae of SARS-CoV-2 in Children;Pediatrics;2024-02-07

4. Favipiravir for the Treatment of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;American Journal of Therapeutics;2024-01-23

5. The effect of COVID‐19 and COVID‐19 vaccination on serum anti‐Mullerian hormone: A systematic review and meta‐analysis;Immunity, Inflammation and Disease;2024-01